Skip to main content
All
Stories
Press Releases
Documents
Events
Statements
Other
Press shift tab to select search category
Loading...
Newsroom
< Back
Newsroom
Press Releases
Media Statements
Media Library
Contacts
Subscribe
Investors
< Back
Investors
Investors
Financial Results
Annual Reports & Accounts
Investor Events
Financial Calendar
Corporate News
Regulated Information
Shareholder Information
Contacts
Subscribe
Careers
< Back
Careers
Careers
Working at Ipsen
Culture
Job Search
Contacts
< Back
Contacts
Contacts
Our Locations
Report Side Effects
Subscribe
All
Stories
Press Releases
Documents
Events
Statements
Other
Press shift tab to select search category
Loading...
English EN
Français FR
EN
English
EN
Français
FR
Global
< Back
Global
EN
FR
Annual Report
EN
FR
Americas
Asia Pacific
Europe
Middle East & Africa
United States
Brazil
Canada
Mexico
Australia
China
Singapore
South Korea
Japan
Belgium
Ukraine
UK
Germany
France
Nordics
Greece
Italy
Netherlands
Spain
Poland
Russia
Slovakia
Czech Republic
Austria
Switzerland
UAE & Gulf
Home
Company
< Back
Company
Company
Leadership
History
Fondation Ipsen
Expertise
< Back
Expertise
Oncology
Rare Disease
Neuroscience
Medicines
Science
< Back
Science
Science
Profiles
Pipeline
Partnering
Clinical Trials
< Back
Clinical Trials
Lay Summaries
Find Clinical Trials
Sustainability
< Back
Sustainability
Sustainability
Environment
Patients
People
Governance
Our Standards
Patients
< Back
Patients
Patients
Together for Oncology
Together for Rare Disease
Together for Neuroscience
Collaborate with us
Stories
Home
Subscribe to receive the latest news
Subscribe to receive the latest news
X
You are now leaving the Ipsen group website.To continue, please click on
Continue
?